Neuropathological evaluation of mixed dementia

Journal of the Neurological Sciences

Volumn 257, Issue 1-2, 2007, Pages 80-87

  Jellinger, K A ^a   Attems, J ^b  

^a INSTITUTE OF CLINICAL NEUROBIOLOGY   (Austria)

^b OTTO WAGNER HOSPITAL   (Austria)

Author keywords

Alzheimer disease; Consensus criteria; Diagnostic accuracy; Mixed dementia; Neuropathology; Vascular encephalopathy

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; AUSTRIA; AUTOPSY; BRAIN DAMAGE; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; DEMENTIA; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; LEWY BODY; MAJOR CLINICAL STUDY; MALE; MIXED DEMENTIA; NEUROIMAGING; NEUROPATHOLOGY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; ALZHEIMER DISEASE; ATROPHY; BRAIN; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBRAL ARTERIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEMENTIA, VASCULAR; HUMANS;

EID: 34249814045     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.01.045     Document Type: Article

References (58)

1. Jellinger K.A. The enigma of mixed dementia. Alzheimer's & Dementia 3 (2007) 40-53
2. Khachaturian Z.S. Diagnosis of Alzheimer's disease. Arch Neurol 42 (1985) 1097-1105
3. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 (1991) 479-486
4. Braak H., and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82 (1991) 239-259
5. Hyman B.T., and Trojanowski J.Q. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56 (1997) 1095-1097
6. Bowler J.V., and Hachinski V. Current criteria for vascular dementia - a critical appraisal. In: Bowler J.V., and Hachinski V. (Eds). Vascular Cognitive Impairment. Preventable Dementia (2003), Oxford Univ. Press, Oxford 1-11
7. Chui H.C. Vascular cognitive impairment: today and tomorrow. Alzheimer's Dement 2 (2006) 185-194
8. Bennett D.A., Schneider J.A., Wilson R.S., Bienias J.L., and Arnold S.E. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol 61 (2004) 378-384
9. Gold G., Bouras C., Canuto A., Bergallo M.F., Herrmann F.R., Hof P.R., et al. Clinicopathological validation study of four sets of clinical criteria for vascular dementia. Am J Psychiatry 159 (2002) 82-87
10. Gold G., Kovari E., Herrmann F.R., Canuto A., Hof P.R., Michel J.P., et al. Cognitive consequences of thalamic, basal ganglia, and deep white matter lacunes in brain aging and dementia. Stroke 36 (2005) 1184-1188
11. Jellinger K.A. The neuropathologic substrates of vascular-ischemic dementia. In: Paul R.H., Cohen R., Ott B.R., and Salloway S. (Eds). Current Clinical Neurology. Vascular Dementia: Cerebrovascular Mechanisms and Clinical Management (2004), Humana Press, Totowa, NJ 23-57
12. Jellinger K.A. Pathology and pathophysiology of vascular cognitive impairment. A critical update. Panminerva Med 46 (2004) 217-226
13. Jellinger K.A. Understanding the pathology of vascular cognitive impairment. J Neurol Sci 229-230 (2005) 57-63
14. Jellinger K.A. The enigma of vascular cognitive disorder and vascular dementia. Acta Neuropathol (2007) 10.1007/s00401-006-0185-2
15. Jellinger K.A., and Attems J. Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer's disease. J Neurol Sci 229-230 (2005) 37-41
16. Kalback W., Esh C., Castano E.M., Rahman A., Kokjohn T., Luehrs D.C., et al. Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease. Neurol Res 26 (2004) 525-5239
17. Greenberg S.M., Gurol M.E., Rosand J., and Smith E.E. Amyloid angiopathy-related vascular cognitive impairment. Stroke 35 (2004) 2616-2619
18. Bailey T.L., Rivara C.B., Rocher A.B., and Hof P.R. The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease. Neurol Res 26 (2004) 573-578
19. Zlokovic B.V. Clearing amyloid through the blood-brain barrier. J Neurochem 89 (2004) 807-811
20. Zlokovic B.V., Deane R., Sallstrom J., Chow N., and Miano J.M. Neurovascular pathways and Alzheimer amyloid beta-peptide. Brain Pathol 15 (2005) 78-83
21. de la Torre J.C. Alzheimer disease as a vascular disorder: nosological evidence. Stroke 33 (2002) 1152-1162
22. Weller R.O., Cohen N.R., and Nicoll J.A.R. Cerebrovascular disease and the pathophysiology of Alzheimer's disease. Implications for therapy. Panminerva Med 47 (2004) 239-251
23. Chui H.C., Victoroff J.I., Margolin D., Jagust W., Shankle R., and Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 42 (1992) 473-480
24. Román G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C., Garcia J.H., et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43 (1993) 250-260
25. Jellinger K.A. Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm 109 (2002) 813-836
26. Giannakopoulos P., Hof P.R., Michel J.P., Guimon J., and Bouras C. Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts. Brain Res Brain Res Rev 25 (1997) 217-245
27. Nagy Z., Esiri M.M., Jobst K.A., Morris J.H., King E.-F., McDonald B., et al. The effects of additional pathology on the cognitive deficit in Alzheimer Disease. J Neuropathol Exp Neurol 56 (1997) 165-170
28. Nolan K.A., Lino M.M., Seligmann A.W., and Blass J.P. Absence of vascular dementia in an autopsy series from a dementia clinic. J Am Geriatr Soc 46 (1998) 597-604
29. Crystal H., and Dickson D. Cerebral infarcts in patients with autopsy proven Alzheimer's disease (abstr.). Neurobiol Aging 23 (2002) 207
30. Fernando M.S., and Ince P.G. Vascular pathologies and cognition in a population-based cohort of elderly people. J Neurol Sci 226 (2004) 13-17
31. Lim A., Tsuang D., Kukull W., Nochlin D., Leverenz J., McCormick W., et al. Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series. J Am Geriatr Soc 47 (1999) 564-569
32. Petrovich H., Ross G.W., Steinhorn S.C., Abbott R.D., Markesberry W., Davis D.G., et al. AD lesions and infarcts in demented and no-demented Japanese-American men. Ann Neurol 57 (2005) 98-103
33. Vermeer S.E., Prins N.D., den Heijer T., Hofman A., Koudstaal P.J., and Breteler M.M. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 348 (2003) 1215-1222
34. Corbett A., Bennett H., and Kos S. Cognitive dysfunction following subcortical infarction. Arch Neurol 51 (1994) 999-1007
35. Zekry D., Duyckaerts C., Belmin J., Geoffre C., Moulias R., and Hauw J.J. Alzheimer's disease and brain infarcts in the elderly. Agreement with neuropathology. J Neurol 249 (2002) 1529-1534
36. Zekry D., Duyckaerts C., Moulias R., Belmin J., Geoffre C., Herrmann F., et al. Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly. Acta Neuropathol (Berl) 103 (2002) 481-487
37. Berg L., McKeel Jr. D.W., Miller J.P., Storandt M., Rubin E.H., Morris J.C., et al. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol 55 (1998) 326-335
38. Riley K.P., Snowdon D.A., and Markesbery W.R. Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Ann Neurol 51 (2002) 567-577
39. Hulette C.M., Welsh-Bohmer K.A., Murray M.G., Saunders A.M., Mash D.C., and McIntyre L.M. Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. J Neuropathol Exp Neurol 57 (1998) 1168-1174
40. Esiri M.M., Nagy Z., Smith M.Z., Barnetson L., and Smith A.D. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 354 (1999) 919-920
41. Lee J.H., Olichney J.M., Hansen L.A., Hofstetter C.R., and Thal L.J. Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease. Arch Neurol 57 (2000) 1474-1479
42. Del Ser T., Hachinski V., Merskey H., and Munoz D.G. Alzheimer's disease with and without cerebral infarcts. J Neurol Sci 231 (2005) 3-11
43. Koistinaho M., and Koistinaho J. Interactions between Alzheimer's disease and cerebral ischemia-focus on inflammation. Brain Res Rev 48 (2005) 240-250
44. Artero S., Tiemeier H., Prins N.D., Sabatier R., Breteler M.M., and Ritchie K. Neuroanatomical localisation and clinical correlates of white matter lesions in the elderly. J Neurol Neurosurg Psychiatry 75 (2004) 1304-1308
45. Garde E., Lykke Mortensen E., Rostrup E., and Paulson O.B. Decline in intelligence is associated with progression in white matter hyperintensity volume. J Neurol Neurosurg Psychiatry 76 (2005) 1289-1291
46. Tullberg M., Fletcher E., DeCarli C., Mungas D., Reed B.R., Harvey D.J., et al. White matter lesions impair frontal lobe function regardless of their location. Neurology 63 (2004) 246-253
47. Du A.-T., Schuff N., Chao L.L., Kornak J., Ezekiel F., Jagust W.J., et al. White matter lesions are associated with cortical atrophy more than entorhinal and hippocampal atrophy. Neurobiol Aging 26 (2005) 553-559
48. Zarow C., Vinters H.V., Ellis W.G., Weiner M.W., Mungas D., White L., et al. Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia. Ann Neurol 57 (2005) 896-903
49. Reed B.R., Eberling J.L., Mungas D., Weiner M., Kramer J.H., and Jagust W.J. Effects of white matter lesions and lacunes on cortical function. Arch Neurol 61 (2004) 1545-1550
50. Wen H.M., Mok V.C., Fan Y.H., Lam W.W., Tang W.K., Wong A., et al. Effect of white matter changes on cognitive impairment in patients with lacunar infarcts. Stroke 35 (2004) 1826-1830
51. van der Flier W.M., van Straaten E.C., Barkhof F., Verdelho A., Madureira S., Pantoni L., et al. Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study. Stroke 36 (2005) 2116-2120
52. Capizzano A.A., Acion L., Bekinschtein T., Furman M., Gomila H., Martinez A., et al. White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer's disease. J Neurol Neurosurg Psychiatry 75 (2004) 822-827
53. van der Flier W.M., van Straaten E.C., Barkhof F., Ferro J.M., Pantoni L., Basile A.M., et al. Medial temporal lobe atrophy and white matter hyperintensities are associated with mild cognitive deficits in non-disabled elderly people: the LADIS study. J Neurol Neurosurg Psychiatry 76 (2005) 1497-1500
54. Schmidt R., Ropele S., Enzinger C., Petrovic K., Smith S., Schmidt H., et al. White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study. Ann Neurol 58 (2005) 610-616
55. Schneider J.A., Wilson R.S., Bienias J.L., Evans D.A., and Bennett D.A. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology 62 (2004) 1148-1155
56. Kovari E., Gold G., Herrmann F.R., Canuto A., Hof P.R., Michel J.P., et al. Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke 35 (2004) 410-414
57. Román G.C. Clinical forms of vascular dementia. In: Paul R.H., Cohen R., Ott B.R., and Salloway S. (Eds). Vascular Dementia: Cerebrovascular Mechanisms and Clinical Management (2005), Human Press Inc., Totowa, NJ 7-21
58. Kalaria R.N., Kenny R.A., Ballard C.G., Perry R., Ince P., and Polvikoski T. Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci 226 (2004) 75-80